MoIDX Open Meeting: August 1, 2022
Open Meeting Notification — Proposed LCD(s) Released for Comment
- MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma DL39345
- MoIDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer DL38576
The Centers for Medicare & Medicaid Services (CMS) assigned Palmetto GBA the task of developing local coverage determinations (LCDs) for processing and reviewing Medicare claims for Jurisdictions J and M. These LCDs can be found utilizing the Proposed LCD by Contractor Report on the Medicare Coverage Database. The entire LCD and related billing and coding article should be completely reviewed prior to the preparation of comments.
An open meeting was held via teleconference only August 1, 2022.
Important reminder: Providers and/or suppliers are cautioned not to make any changes based upon the information contained in a proposed LCD. Proposed LCDs are often substantially revised based upon the comments received. Revisions will be considered once all comments have been reviewed. The final LCD will be published in the CMS Medicare Coverage Database and on individual contractors’ websites, allowing for a minimum of 45-days’ public notice before the LCD becomes effective.
Refer to each contractor’s web site for additional information about LCD development and for copies of the draft LCDs.
Meeting Documents
- Open Meeting Agenda (PDF)
- Open Meeting Transcript (PDF)
- Meeting Video Recording